← Back to Search

e-HERO 2.0 for HIV/AIDS (e-HERO Trial)

N/A
Recruiting
Led By Julie Baldwin, Ph.D.
Research Sponsored by Northern Arizona University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month and 3 months
Awards & highlights

e-HERO Trial Summary

This trial seeks to reduce HIV & syphilis in rural OK men, by increasing testing, condom use & PrEP uptake. It will refine an intervention in partnership with local mentors & assess its impact.

Who is the study for?
The e-HERO trial is for young men aged 17 to 29 who live in rural Oklahoma and identify as American Indian or are gay, bisexual, or other men who have sex with men. Participants must be able to follow the study's procedures throughout its duration. Those already diagnosed with HIV cannot join.Check my eligibility
What is being tested?
This study tests an intervention called e-HERO aimed at increasing HIV/syphilis testing, condom use, and PrEP uptake among sexual minority and American Indian men in rural Oklahoma. It involves refining strategies with a Community Advisory Board and peer mentors.See study design
What are the potential side effects?
Since this trial focuses on behavioral interventions rather than medications, traditional side effects like those seen with drugs are not applicable. However, participants may experience social or psychological impacts from the intervention.

e-HERO Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month and 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
HIV testing uptake
Secondary outcome measures
Condom use
HIV testing intention
PrEP consult with medical provider
+1 more

e-HERO Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: e-HERO 2.0Experimental Treatment1 Intervention
The e-HERO intervention includes 10 modules, totaling approximately 2.5 hours of content. Across these modules, e-HERO uses diverse delivery methods to address HIV and STI knowledge, behavioral skills, HIV and STI testing intention, and instill self-efficacy to primary and secondary prevention behaviors. Those in the intervention condition will also engage in three virtual group discussion sessions with peer mentors.
Group II: e-HERO 1.0Active Control1 Intervention
e-HERO 1.0 contains the same number of modules as e-HERO. The control arm reflects HIV and STI information that is currently publicly available.

Find a Location

Who is running the clinical trial?

National Institute on Minority Health and Health Disparities (NIMHD)NIH
393 Previous Clinical Trials
1,221,711 Total Patients Enrolled
Northern Arizona UniversityLead Sponsor
32 Previous Clinical Trials
6,522 Total Patients Enrolled
Oklahoma State UniversityOTHER
46 Previous Clinical Trials
7,980 Total Patients Enrolled
~20 spots leftby Aug 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top